The most frequently prescribed oral antidiabetic drug metformin significantly affects metabolic pathways, report scientists. Metformin is a widespread oral medication to increase insulin sensitivity in patients with type 2 diabetes (T2D). According to a number of studies, it additionally reduces the risk of cardiovascular complications.